M. D. Anderson Cancer Center - News Releases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Conversation With a Living Legend® in Washington, D.C., presented by MD Anderson, raises $5.2 million
President Bill Clinton and General Colin Powell were honored at A Conversation With a Living Legend® in Washington, D.C., April 21 at the John F. Kennedy Center for the Performing Arts. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 27, 2015 Category: Cancer & Oncology Source Type: news

Toxic Mushroom-based Drug May Help Battle Colorectal Cancer
For some time, cancer scientists have considered the toxin, alpha-amanatin derived from "death cap" mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an effective therapy has been limited. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 22, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson Study Points to Potential New Lung Cancer Therapy
New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 20, 2015 Category: Cancer & Oncology Source Type: news

Moon Shots Program researchers to contribute to new Stand Up to Cancer Dream Teams
Researchers at The University of Texas MD Anderson Cancer Center will test combinations of targeted therapy and immunotherapy against lung cancer driven by an untreatable genetic mutation and seek to prevent ovarian cancer in women at high risk for the disease, vital objectives of two new Stand Up to Cancer Dream Teams. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 20, 2015 Category: Cancer & Oncology Source Type: news

Long Non-Coding RNA Modulates Colorectal Cancer Metabolism
Long non-coding RNAs (lncRNA) are unusual in that they don't encode proteins like normal RNA. Yet they do play a role in regulating cellular functions and interest cancer researchers. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 20, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson Study Seeks Earlier Ovarian Cancer Detection
Successful ovarian cancer treatment often relies on catching it early. A study at The University of Texas MD Anderson Cancer Center may help point to a new method for women at risk. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 20, 2015 Category: Cancer & Oncology Source Type: news

New Subsets of Lung Cancer with KRAS Gene Mutations Identified
Mutations of the KRAS gene are commonly known to lead to cancer. However, deeper understanding of exactly how they do this continues to be explored by cancer researchers. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 19, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson Researcher James Allison, Ph.D., Receives Pezcoller Award
Cancer scientist James Allison, Ph.D., internationally known for his role in developing a new class of cancer immunotherapies, has been named a recipient of the 2015 Pezcoller Foundation-American Association for Cancer Research (AACR) International Award for Cancer Research. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 16, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson's Keeling Center Open House Set for April 24
The University of Texas MD Anderson Cancer Center's Michale E. Keeling Center for Comparative Medicine and Research will open its doors to the community from 3 p.m. to 7 p.m. Friday, April 24. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 15, 2015 Category: Cancer & Oncology Source Type: news

Get ready to two-step: Polo on the Prairie returns April 25
The Texas drought has touched countless fields and ranches across West Texas. But longtime MD Anderson Cancer Center Board of Visitors member Henry Musselman and his wife, Melinda, won't let it stop them from hosting their annual fundraiser for The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 13, 2015 Category: Cancer & Oncology Source Type: news

Review highlights potential of cancer immunotherapy plus targeted therapy
The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests "we are finally poised to deliver curative therapies to cancer patients," researchers at The University of Texas MD Anderson Cancer Center note in a review in the April 9 edition of Cell. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 9, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson, Astellas Pharma Sign Option Agreement
The University of Texas MD Anderson Cancer Center and Astellas Pharma Inc. have signed an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML). (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 3, 2015 Category: Cancer & Oncology Source Type: news

Strong grasp of immune response dynamics will enhance checkpoint blockade
Spreading the success of cancer immunotherapy beyond those patients currently enjoying powerful, long-term responses to treatment requires greater understanding of the immune response to tumors, two leaders in the field note in a review in the April 3 Science. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 2, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson and NanoString Technologies Announce Multi-Year Collaboration
The University of Texas MD Anderson Cancer Center and NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year collaboration to accelerate the development and adoption of a new type of assay based on NanoString's nCounter Analysis System. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - April 1, 2015 Category: Cancer & Oncology Source Type: news

Sentinel lymph node mapping identifies positive lymph nodes in women with high-risk endometrial cancer, MD Anderson study finds
n a study of women with high-grade endometrial cancer, researchers at The University of Texas MD Anderson Cancer Center, found sentinel lymph node (SLN) mapping accurately identified all women with node-positive, high-risk endometrial cancer, when prospectively compared to a complete pelvic and para-aortic lyphadenectomy (LAD), the current standard of care. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - March 31, 2015 Category: Cancer & Oncology Source Type: news